The National Organization for Rare Disorders (NORD) has updated its State Report Card to make it more digitally friendly and added telehealth to its categories of rare disease policy issues in a nod to its increased use during the ongoing COVID-19 pandemic. NORD’s report card project began seven…
Due to the coronavirus pandemic, the year 2020 was unprecedented, not only for the U.S., but for the entire world as well. So many things have happened, but none were more difficult to respond to than the pandemic. And we’re still dealing with it. The coronavirus has affected every industry…
The Phase 3 GRACE clinical trial evaluating Corcept Therapeutics‘ relacorilant as a potential treatment for high blood pressure and poor glucose tolerance in people with endogenous Cushing’s syndrome is expected to take longer to complete, the company announced. While patients in the GRACE study continue to…
Get regular updates to your inbox.